{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:47:34Z","timestamp":1794592054012,"version":"4.9.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["New Microbes and New Infections"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.nmni.2026.101742","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:21:40Z","timestamp":1774628500000},"page":"101742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Vancomycin MIC creep and the emergence of oxacillin-susceptible MRSA: A three-year surveillance study from a tertiary care centre"],"prefix":"10.1016","volume":"71","author":[{"given":"Kavita","family":"Sisodia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpita","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitha","family":"Haridas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dabet","family":"Rynga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharmender","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajni","family":"Gaind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmni.2026.101742_bib1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4103\/JLP.JLP_39_19","article-title":"Recent pattern of antibiotic resistance in Staphylococcus aureus clinical isolates in Eastern India and the emergence of reduced susceptibility to vancomycin","volume":"11","author":"Mohanty","year":"2019","journal-title":"J Lab Physicians"},{"key":"10.1016\/j.nmni.2026.101742_bib2","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.6749","article-title":"Minimum inhibitory concentrations of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus isolated from various clinical specimens: a study from South India","author":"Moses","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.nmni.2026.101742_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00042-09","article-title":"Reduced vancomycin susceptibility in Staphylococcus aureus , including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications","volume":"23","author":"Howden","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.nmni.2026.101742_bib5","series-title":"Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. CLSI document M100-S16","year":"2006"},{"key":"10.1016\/j.nmni.2026.101742_bib6","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2024"},{"key":"10.1016\/j.nmni.2026.101742_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1128\/JCM.01128-10","article-title":"Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus , with the population analysis profile method as the reference method","volume":"49","author":"Satola","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.nmni.2026.101742_bib8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/emmm.201202413","article-title":"Whole genome sequencing identifies zoonotic transmission of MRSA isolates with the novel mecA homologue mecC","volume":"5","author":"Harrison","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.nmni.2026.101742_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73796-5","article-title":"Identification and characterization of mutations responsible for the \u03b2-lactam resistance in oxacillin-susceptible mecA-positive Staphylococcus aureus","volume":"10","author":"Boonsiri","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.nmni.2026.101742_bib10","series-title":"Antimicrobial resistance research and surveillance network (AMRSN) annual report 2023","year":"2023"},{"key":"10.1016\/j.nmni.2026.101742_bib11","series-title":"Mackie & McCartney practical medical microbiology","year":"1996"},{"key":"10.1016\/j.nmni.2026.101742_bib12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infection"},{"key":"10.1016\/j.nmni.2026.101742_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmmb.2025.100871","article-title":"Phenotypic and genotypic characterization of MRSA isolated from health care workers in tertiary care hospital","volume":"56","author":"Sisodia","year":"2025","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.nmni.2026.101742_bib14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1128\/JCM.02432-13","article-title":"Performance of Vitek 2 for antimicrobial susceptibility testing of staphylococcus spp. and enterococcus spp","volume":"52","author":"Bobenchik","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.nmni.2026.101742_bib15","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1128\/AAC.01073-08","article-title":"Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey medical center","volume":"52","author":"Kosowska-Shick","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nmni.2026.101742_bib17","doi-asserted-by":"crossref","DOI":"10.5001\/omj.2022.22","article-title":"Prevalence of methicillin-resistant Staphylococcus aureus in India: a systematic review and meta-analysis","volume":"37","author":"Patil","year":"2022","journal-title":"Oman Med J"},{"key":"10.1016\/j.nmni.2026.101742_bib18","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jhin.2021.09.022","article-title":"Joint healthcare infection society (HIS) and infection prevention society (IPS) guidelines for the prevention and control of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities","volume":"118","author":"Coia","year":"2021","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.nmni.2026.101742_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.33","article-title":"Methicillin-resistant Staphylococcus aureus","volume":"4","author":"Lee","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.nmni.2026.101742_bib20","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.22207\/JPAM.17.3.13","article-title":"Role of oxacillin susceptibility testing strategy in changing scenario of mecA positive Staphylococcus aureus isolates (OS-MRSA) detection","volume":"17","author":"Dhar","year":"2023","journal-title":"J Pure Appl Microbiol"},{"key":"10.1016\/j.nmni.2026.101742_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10156-006-0502-7","article-title":"Characterization of oxacillin-susceptible mecA-positive staphylococcus aureus: a new type of MRSA","volume":"13","author":"Hososaka","year":"2007","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.nmni.2026.101742_bib22","doi-asserted-by":"crossref","first-page":"dkv261","DOI":"10.1093\/jac\/dkv261","article-title":"Frequent occurrence of oxacillin-susceptible mecA -positive Staphylococcus aureus (OS-MRSA) strains in two African countries: table 1","author":"Concei\u00e7\u00e3o","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.nmni.2026.101742_bib23","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.2147\/IDR.S317670","article-title":"First report of oxacillin susceptible mecA-Positive Staphylococcus aureus in a children's hospital in Kunming, China","volume":"14","author":"Ma","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.nmni.2026.101742_bib24","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jmii.2020.07.021","article-title":"Current status of oxacillin-susceptible mecA-positive Staphylococcus aureus infection in Shanghai, China: a multicenter study","volume":"54","author":"Liu","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.nmni.2026.101742_bib25","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s10096-023-04646-1","article-title":"Phenotypic and genomic characteristics of oxacillin-susceptible mecA-positive Staphylococcus aureus, rapid selection of high-level resistance to beta-lactams","volume":"42","author":"Gostev","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.nmni.2026.101742_bib26","first-page":"262","article-title":"Oxacillin-susceptible methicillin-resistant Staphylococcus aureus septic bursitis identified following clinical failure with \u03b2-lactam therapy: a case report","volume":"10","author":"Kipp","year":"2025","journal-title":"J Assoc Med Microbiol Infect Dis Canada"},{"key":"10.1016\/j.nmni.2026.101742_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162256","article-title":"Prevalence and characterization of oxacillin susceptible mecA-Positive clinical isolates of Staphylococcus aureus causing bovine mastitis in India","volume":"11","author":"Mistry","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.nmni.2026.101742_bib28","doi-asserted-by":"crossref","first-page":"105286","DOI":"10.1016\/j.prevetmed.2021.105286","article-title":"First report of oxacillin-susceptible mecA-positive Staphylococcus aureus in healthy dogs and their owners in southern Brazil","volume":"189","author":"Fabri","year":"2021","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.nmni.2026.101742_bib29","first-page":"363","article-title":"Methicillin resistant Staphylococcus aureus (MRSA) in India: prevalence & susceptibility pattern","volume":"137","author":"Joshi","year":"2013","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.nmni.2026.101742_bib30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.26719\/2016.22.3.193","article-title":"Accuracy of the VITEK 2 system for a rapid and direct identification and susceptibility testing of Gram-negative rods and Gram-positive cocci in blood samples","volume":"22","author":"Nimer","year":"2016","journal-title":"East Mediterr Health J"},{"key":"10.1016\/j.nmni.2026.101742_bib31","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.22207\/JPAM.18.3.36","article-title":"Tracking vancomycin MIC creep: a five year analysis","volume":"18","author":"Devhare","year":"2024","journal-title":"J Pure Appl Microbiol"},{"key":"10.1016\/j.nmni.2026.101742_bib32","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jinf.2009.11.011","article-title":"Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong","volume":"60","author":"Ho","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.nmni.2026.101742_bib33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4103\/0255-0857.148837","article-title":"Vancomycin MIC creep in methicillin-resistant Staphylococcus aureus (MRSA) isolates from 2006 to 2010 in a hospital in China","volume":"33","author":"Chang","year":"2015","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.nmni.2026.101742_bib34","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jac\/dkm258","article-title":"Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001 05","volume":"60","author":"Steinkraus","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.nmni.2026.101742_bib35","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s15010-023-02036-5","article-title":"Decrease in vancomycin MICs and prevalence of hGISA in MRSA and MSSA isolates from a German pediatric tertiary care center","volume":"51","author":"Haas","year":"2023","journal-title":"Infection"},{"key":"10.1016\/j.nmni.2026.101742_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3889\/oamjms.2019.009","article-title":"Vancomycin MIC distribution among methicillin-resistant staphylococcus aureus. Is reduced vancomycin susceptibility related to MIC creep?","volume":"7","author":"Othman","year":"2018","journal-title":"Open Access Maced J Med Sci"},{"key":"10.1016\/j.nmni.2026.101742_bib37","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1186\/s12879-024-10047-2","article-title":"Reduced vancomycin susceptibility in Staphylococcus aureus clinical isolates: a spectrum of less investigated uncertainties","volume":"24","author":"Tawfeek","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.nmni.2026.101742_bib38","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1128\/JCM.01388-06","article-title":"Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-Year period","volume":"44","author":"Wang","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.nmni.2026.101742_bib39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1099\/jmm.0.011940-0","article-title":"Decreased susceptibility to vancomycin in meticillin-resistant staphylococcus aureus: a 5 year study in an Indian tertiary hospital","volume":"59","author":"Dhawan","year":"2010","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.nmni.2026.101742_bib40","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1473-3099(09)70200-2","article-title":"Susceptibility relationship between vancomycin and daptomycin in staphylococcus aureus: facts and assumptions","volume":"9","author":"Moise","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.nmni.2026.101742_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00324-17","article-title":"Efficacy of ceftaroline against methicillin-susceptible Staphylococcus aureus exhibiting the cefazolin high-inoculum effect in a rat model of endocarditis","volume":"61","author":"Singh","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nmni.2026.101742_bib42","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jiph.2020.07.008","article-title":"Occurrence of vancomycin MIC creep in methicillin resistant isolates in Saudi Arabia","volume":"13","author":"Aljohani","year":"2020","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.nmni.2026.101742_bib43","article-title":"Assessment of vancomycin MIC creep phenomenon in methicillin-resistant Staphylococcus aureus isolates in a tertiary care hospital of lahore","volume":"36","author":"Arshad","year":"2020","journal-title":"Pakistan J Med Sci"}],"container-title":["New Microbes and New Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297526000466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297526000466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T13:57:30Z","timestamp":1779717450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2052297526000466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":41,"alternative-id":["S2052297526000466"],"URL":"https:\/\/doi.org\/10.1016\/j.nmni.2026.101742","relation":{},"ISSN":["2052-2975"],"issn-type":[{"value":"2052-2975","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vancomycin MIC creep and the emergence of oxacillin-susceptible MRSA: A three-year surveillance study from a tertiary care centre","name":"articletitle","label":"Article Title"},{"value":"New Microbes and New Infections","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmni.2026.101742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101742"}}